Total Payments
$7,228
2024 Payments
$512.81
Companies
36
Transactions
389
Medicare Patients
3,786
Medicare Billing
$537,276
Payment Breakdown by Category
Food & Beverage$6,939 (96.0%)
Education$289.07 (4.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,939 | 380 | 96.0% |
| Education | $289.07 | 9 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,266 | 69 | $0 (2023) |
| Novo Nordisk Inc | $708.68 | 54 | $0 (2024) |
| ABBVIE INC. | $548.86 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $543.98 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $486.48 | 25 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $447.52 | 17 | $0 (2024) |
| Intra-Sana Laboratories | $342.63 | 11 | $0 (2024) |
| Lilly USA, LLC | $309.26 | 16 | $0 (2024) |
| Gilead Sciences, Inc. | $306.75 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $253.81 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $512.81 | 22 | Intra-Sana Laboratories ($137.89) |
| 2023 | $1,010 | 36 | Bayer Healthcare Pharmaceuticals Inc. ($328.98) |
| 2022 | $786.63 | 37 | ABBVIE INC. ($117.44) |
| 2021 | $1,044 | 52 | AbbVie Inc. ($294.46) |
| 2020 | $467.36 | 30 | AstraZeneca Pharmaceuticals LP ($185.88) |
| 2019 | $738.97 | 43 | AstraZeneca Pharmaceuticals LP ($282.34) |
| 2018 | $1,233 | 70 | AstraZeneca Pharmaceuticals LP ($242.09) |
| 2017 | $1,436 | 99 | AstraZeneca Pharmaceuticals LP ($347.85) |
All Payment Transactions
389 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: GALLSTONES | ||||||
| 12/02/2024 | Intra-Sana Laboratories | GLYCATE (Drug), RELTONE 400 MG, RELTONE 200 MG | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: PEPTIC ULCER DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: GALLSTONES | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Gastroenterology | ||||||
| 07/15/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: GALLSTONES | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: GALLSTONES | ||||||
| 04/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: GALLSTONES | ||||||
| 02/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Cardio-renal | ||||||
| 02/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardio-renal | ||||||
| 12/20/2023 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: GALLSTONES | ||||||
| 12/12/2023 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: GALLSTONES | ||||||
| 12/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 997 | 1,857 | $285,330 | $152,010 |
| 2022 | 17 | 985 | 1,954 | $295,945 | $144,570 |
| 2021 | 19 | 957 | 1,680 | $250,070 | $124,336 |
| 2020 | 15 | 847 | 1,612 | $244,535 | $116,360 |
Total Patients
3,786
Total Services
7,103
Medicare Billing
$537,276
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 358 | $62,650 | $28,841 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 221 | $44,200 | $24,823 | 56.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 46 | 244 | $36,600 | $23,658 | 64.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 43 | 105 | $20,970 | $14,063 | 67.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $16,700 | $12,216 | 73.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 85 | 180 | $22,500 | $11,810 | 52.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 122 | $12,200 | $5,624 | 46.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 35 | $12,250 | $5,538 | 45.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 36 | 45 | $9,495 | $5,478 | 57.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 27 | 30 | $10,140 | $4,890 | 48.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $6,400 | $3,378 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $2,170 | 62.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 29 | $4,350 | $2,144 | 49.3% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 58 | 80 | $6,000 | $2,115 | 35.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 24 | $4,800 | $1,865 | 38.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 175 | $3,500 | $1,470 | 42.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 19 | $2,375 | $819.54 | 34.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 48 | $6,000 | $603.68 | 10.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $700.00 | $503.72 | 72.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 127 | 381 | $47,625 | $24,253 | 50.9% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 66 | 186 | $37,200 | $22,663 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 196 | $39,200 | $21,935 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 239 | $41,850 | $19,676 | 47.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 103 | 120 | $42,000 | $18,127 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $13,400 | $10,299 | 76.9% |
About Dr. Jonathan Selzer, MD
Dr. Jonathan Selzer, MD is a Internal Medicine healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265404271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Selzer, MD has received a total of $7,228 in payments from pharmaceutical and medical device companies, with $512.81 received in 2024. These payments were reported across 389 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,939).
As a Medicare-enrolled provider, Selzer has provided services to 3,786 Medicare beneficiaries, totaling 7,103 services with total Medicare billing of $537,276. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bronx, NY
- Active Since 02/03/2006
- Last Updated 03/13/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265404271
Products in Payments
- FARXIGA (Drug) $1,015
- XARELTO (Drug) $474.44
- Kerendia (Drug) $447.52
- VRAYLAR (Drug) $384.58
- Saxenda (Drug) $279.72
- JARDIANCE (Drug) $272.62
- CONTRAVE (Drug) $229.81
- TRELEGY ELLIPTA (Drug) $207.60
- RELTONE 200 MG (Drug) $191.24
- UBRELVY (Drug) $168.79
- MYRBETRIQ (Drug) $167.99
- Movantik (Drug) $159.63
- GLYCATE (Drug) $151.39
- BEVESPI AEROSPHERE (Drug) $140.65
- Ozempic (Drug) $126.75
- MOUNJARO (Drug) $125.80
- Truvada (Drug) $120.53
- Edarbi (Drug) $115.51
- ELIQUIS (Drug) $113.54
- Myrbetriq (Drug) $109.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bronx
Timothy Kanter, M.d, M.D
Internal Medicine — Payments: $865,160
Internal Medicine $865,160
Dr. Jason Leider, M.d, M.D
Internal Medicine — Payments: $759,257
Internal Medicine $759,257
Bulent Atac, Md, MD
Internal Medicine — Payments: $654,500
Internal Medicine $654,500
Shervin Mortazavi, M.d, M.D
Internal Medicine — Payments: $402,598
Internal Medicine $402,598
Dr. Elizabeth Jenny-Avital
Internal Medicine — Payments: $176,355
Internal Medicine $176,355
Vivek Gumaste, M.d, M.D
Internal Medicine — Payments: $163,229
Internal Medicine $163,229